Perrigo Sued Over ANDA For Psoriasis Shampoo

Law360, New York (August 18, 2010, 5:11 PM EDT) -- Galderma Laboratories LP has launched a patent infringement suit against a Michigan pharmaceutical company and its Israeli unit for allegedly attempting to market a generic form of psoriasis-treating hair product Clobex.

Allegan, Mich.-based Perrigo Co. and subsidiary Perrigo Israel Pharmaceutical Ltd. intend to infringe two patents for clobetasol propionate shampoo (0.05 percent), known commercially as Clobex, as evidenced by an abbreviated new drug application filed with the U.S. Food and Drug Administration, Galderma complained Tuesday in the U.S. District Court for the Northern District of Texas....
To view the full article, register now.